Access Bio Korea was established as a 100% subsidiary of Access Bio in the United States. Currently, rapid diagnostic kits are in the spotlight due to the global COVID-19 crisis, and we produce antibody/antigen identification diagnostic kits for COVID-19 as our main item. It also produces items from Wells Bio Co., Ltd., a subsidiary in Korea, and is sold worldwide in Asia, the Middle East, and Europe. In addition to products related to COVID-19, we produce Flu A&B and Dengue products as our main items. Our factory has acquired GMP and ISO and is constantly striving to improve productivity and quality.
Looking for a particular AccessBio Korea employee's phone or email?
AccessBio Korea Questions
The AccessBio Korea annual revenue was $31.4 million in 2026.
Joy Cavagnaro is the President of AccessBio Korea.
1 people are employed at AccessBio Korea.
AccessBio Korea is based in Somerset, New Jersey.
The NAICS codes for AccessBio Korea are [339, 33, 334].
The SIC codes for AccessBio Korea are [38, 384].
Top AccessBio Korea Employees
-
Joy Cavagnaro
President at AccessBio Korea
Boyce, VA, US24
Related Companies
